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Background. There is an increasing need for programmatic prevention of cardiometabolic dis-
eases (cardiovascular disease, type 2 diabetes and chronic kidney disease). Therefore, in the
Netherlands, a prevention programme linked to primary care has been developed. This initiative
was supported by the national professional organizations of GPs and occupational physicians as
well as three large health foundations.
Objectives. Todescribeanddiscussthecontent,structureofandﬁrstexperienceswiththisinitiative.
Methods. Description of context, risk assessment tool, guideline, content of the Prevention
Consultation and pilot studies.
Results. Preceding surveys revealed a need for proactive disease prevention, linked to primary
care. An evidence-based guideline was developed using a validated eight-question screening
list. According to the guideline, high-risk participants were advised to attend two consultations
at the general practice, for completing the risk assessment and for tailored advice. Three pilot
studies revealed that the programme was feasible and that (sufﬁcient) participants with a condi-
tion requiring treatment were detected. We learned that with a ‘passive’ recruitment (with only
posters and brochures), screening uptake is limited. A more active approach with a personal
invitation from the GP is more effective. Both an Internet as written questionnaire should be
available and reminders are necessary. The need for a consultation with the GP practice after
a high-risk test result should be emphasized. The ﬁrst consultation can be performed by a
practice nurse.
Conclusions. A national systematic screening programme for cardiometabolic diseases linked to
primary care is feasible. The cost-effectiveness still has to be established.
Keywords. Cardiovascular disease, diabetes, hypertension, kidney disease, prevention, primary
care, screening, the Netherlands.
Introduction
Cardiovascular diseases (CVDs), type 2 diabetes (DM2)
and chronic kidney diseases (CKDs) are three of the
most common and most burdensome chronic diseases
in the western world.
1 For this reason, prevention of
these diseases receives increasing attention. Primary
care plays an important role in this.
2
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the Netherlands with an evidence-based integrated
approach to prevention, which is well embedded in
regular primary health care. We felt the need for this
initiative because over the past years the Dutch gov-
ernment, not-for-proﬁt organizations and for-proﬁt
companies had set up various initiatives to make the
public aware of the importance to assess their risk pro-
ﬁle and to encourage people at risk to take action in
order to prevent these diseases.
Although all these initiatives worked towards the
same goal, namely the early detection of risk factors
and appropriate interventions, several threats could
be identiﬁed:
The diversity in health checks, screening tools and
interventions was confusing for the general public.
The quality of the available health checks was some-
times questionable; at the same time, lay persons may
not have the knowledge to distinguish the better qual-
ity checks from the lesser quality checks.
Health professionals lacked sufﬁcient skills and know-
ledge for detecting and managing high-risk patients.
People who were identiﬁed as ‘at risk’ often did not
know where to go next and what to do to reduce their
risk.
3 A follow-up in regular health care was not ar-
ranged properly or not at all.
To contribute to similar initiatives in other coun-
tries, we will discuss the development of a guideline,
lessons learned from the pilot studies and challenges
in further implementation and research.
Background and content of the evidence-
based guideline
In the Netherlands, the above-mentioned threats drove
the need for an evidence-based integrated approach to
prevention, which is well embedded in regular health
care. We chose for a single strategy for the prevention
and early detection of CVD, DM2 and CKD since the
link between CVD and DM2 has been well documented
and both CVD and DM2 play a role in the aetiology
of CKD. Furthermore, all the three diseases have
similar determinants for development and progression
of these diseases. In many cases, these can be prevented
or delayed by a healthy lifestyle consisting of sufﬁcient
physical activity, a healthy diet and smoking cessation.
In the Netherlands, several recent surveys indicated
that screening for cardiometabolic disorders could be
more efﬁcient and acceptable when it is embedded in
the health care setting.
4,5 In the Netherlands, the GP
plays an important role in preventing CVD, type2 dia-
betes mellitus and kidney disease
6 since (i) all Dutch
inhabitants are registered obligatory with a general
practice and 75% visit their GP at least once a year;
(ii) GPs keep electronic medical records of all listed
patients and (iii) patients highly trust their GP.
3,6 In ad-
dition, Dutch GPs have successfully been involved in
other prevention programmes, such as inﬂuenza vacci-
nation and cervical cancer screening. A recent survey
showed that Dutch GPs have a positive attitude to-
wards integrated primary prevention of cardiometabolic
diseases and they consider general practice the right
care setting for detecting and treating patients at risk
for these diseases.
7
Therefore, the Dutch College of General Practi-
tioners (NHG), the Dutch National Association of Gen-
eral Practitioners (LHV) and the Netherlands Society
of Occupational Medicine (NVAB) together with three
health foundations (Netherlands Heart Foundation,
Dutch Diabetes Research Foundation and Dutch Kid-
ney Foundation) developed an evidence-based guideline
[PreventieConsult (PreventionConsultation) cardio-
metabolic risk (CMR)] to improve the early detection
and management of patients with an increased risk for
CVD, DM2 and CKD.
8,9
The guideline PreventieConsult CMR was published
in its deﬁnite form in 2011, after being piloted. The
guideline was validated by an authorizing committee of
experts, after an external review procedure among ex-
ternal experts and practicing GPs. It was developed to
improve the early detection and treatment of persons
with an increased risk for cardiometabolic disorders
(CVD, DM2 and CKD). All individuals between 45
and 70 years of age without known cardiometabolic dis-
eases and who do not use anti-hypertensive or lipid-
lowering treatment are eligible for the PreventieConsult
CMR (for certain ethnic groups of South Asian origin
the lower age limit is set at 35 years).
10 The Preventie-
Consult CMR is based on current evidence regarding
cardiometabolic risk estimation and includes a stepwise
approach (Fig. 1). Based on a risk estimation (ﬁrst
step), patients with a high-risk score are referred to the
general practice (second step).
First step: risk estimation
The ﬁrst step of the PreventieConsult CMR is an inte-
grated risk estimation for the three cardiometabolic
diseases.
8,9 This risk estimation has speciﬁcally been
developed for persons who have not yet been diagnosed
with any of these diseases nor with a treatable risk factor
(e.g. hypertension or hypercholesterolaemia) and is
therefore speciﬁcally suitable for prevention in the
general public or high-risk groups. The risk estimation
contains elements from the SCORE risk function
11 and
the already validated FINDRISK questionnaire.
12 The
eight items that can be ﬁlled out by self-report are age,
gender, body mass index (BMI), waist circumference,
current smoking, family history of myocardial infarction
or stroke and family history of type 2 diabetes mellitus.
9
Scores per item are gender speciﬁc and the sum score
indicates the total risk estimation. The risk score was
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cohorts from different Netherlands regions
8,9 (see also
M Alssema, RS Newson, SJL Bakker et al., unpublished
work). The predicted outcome is the incidence of any
cardiometabolic disease. Based on the sum score, partici-
pants are categorized as having a below or above thresh-
old risk for a cardiometabolic disease
8,9 (see also
M Alssema, RS Newson, SJL Bakker et al., unpublished
work). Persons with a normal risk score (below the thresh-
old) receive a general or tailored lifestyle advice, based on
the present risk factors (Fig. 1). Persons with a high-risk
score (above the threshold) are advised to visit their GP
for the second step of the PreventieConsult CMR.
Second step: follow-up of high risk at the general
practice
In the second step of the PreventieConsult CMR, per-
sons estimated as having a high-risk score according to
the risk estimation are advised to visit their general
practice for two prevention consultations with a GP or
practice nurse (PN). During these consultations, the
complete risk proﬁle will be assessed and follow-up
actions will be discussed. The risk proﬁle includes the
assessments of serum cholesterol ratio (total cholesterol
and high-density lipoprotein), glucose level and blood
pressure measurements in order to estimate the 10-year
risk on cardiovascular mortality
11 and/or to establish
a diagnosis of diabetes. Follow-up actions usually in-
clude lifestyle advice and/or starting with (preventive)
drug treatment (e.g. lipid-lowering drugs). In the guide-
line, the local availability of a variety of evidence-based
lifestyle programmes is considered an essential require-
ment for initiating the PreventionConsultation. At pres-
ent, many local and nationwide integrated lifestyle
programmes have been developed, such as the Be-
weegkuur (exercise on prescription) and smoking
cessation programmes. We ensured that the inclusion
criteria for these programmes are identical to the indica-
tions derived from the PreventieConsult. In additions to
speciﬁc programmes, persons can also be referred to
physiotherapists for exercise programmes and/or dieti-
cians for dietary advice.
Pilot studies: ﬁndings and adaptations made
To test the feasibility of the PreventieConsult CMR
in a general practice setting, three pilots have been
conducted.
Pilot 1: Nielen et al.
In 2009, the PreventieConsult CMR was piloted in 16
general practices.
13 Patients between 45 and 70 years
of age without known cardiometabolic disorders were
invited to ﬁll in an online questionnaire, which re-
sulted in a low-, medium- or high-risk scores for cardi-
ometabolic diseases (only after this pilot, the score
was dichotomized). Half of the participating practices
invited patients with a personal letter. In the other
practices, patients were invited via leaﬂets and posters
in the waiting room. The response rates to the invita-
tion letter (active approach) and posters and leaﬂets
(passive approach) were 33% and 1%, respectively.
Initially, the response was low and slow, but this in-
creased after a reminder letter from the GP. In total,
617 patients completed the online risk questionnaire,
of which 392 persons (64%) had a high-risk score for
General life style advice 
Questionnaire 
Risk score above threshold  Risk score below threshold 
1
st consultation 
- History 
- Physical examination  
- Lab tests 
Tailored life style advice 
Tailored life style advice  
Management and follow-up 
according to existing disease-
oriented guidelines 
No risk factors present  Risk factors present 
2
nd consultation 
- Determination of risk profile  
- Counselling on risk 
FIGURE 1 Design PreventieConsult CMR
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patients visiting their GP. In 28 of these patients
(20%), one or more CVDs, DM2, CKD or risk factors
for these (like hypertension or hypercholesterolaemia)
were detected.
13 The online risk estimation question-
naire identiﬁed 21% as current smokers (129 of 617)
and overweight (BMI > 25) in 53% (327 of 617).
A questionnaire to a random sample of non-responders
showed that concerns about privacy was the most
frequently mentioned reason for non-participation.
The invitation or participation did not increase anxi-
ety. Of the non-participants, 24% reported to have
limited access to Internet (versus 11% of participants).
The pilot study also addressed the experiences and
attitudes of the practice staff. Almost 90% of the par-
ticipating GPs and PNs stated that the general practice
is a suitable place for prevention activities as re-
commended in the PreventieConsult CMR guideline.
Eighty-nine per cent of the GPs and PNs were of the
opinion that these preventive activities can very well be
done by the PNs.
13 The participating practices reported
that the ﬁrst consultation was performed by either the
PN or the GP and took on average 24 and 14 minutes,
respectively. The average duration of the second con-
sultation (always with the GP) took 14 minutes.
Two other pilot
Van de Kerkhof et al.
14 and Klomp et al.
15 used other
age limits and invited patients aged 40–75 years (1704
and 2529 patients, respectively). Another difference
was the availability of a written version of the question-
naire. Most ﬁndings were similar to those of Nielen
et al.
13 However, the response to the questionnaire
was higher, namely 69%
14 and 75%
15,r e s p e c t i v e l y .
Based on the information provided, respectively,
55%
14 and 29%
15 were invited for an additional per-
sonal examination. Similar to the study from Nielen
et al.,
13 in both pilots one in one of ﬁve attenders, a con-
dition was diagnosed that needed either treatment or
follow-up according to the prevailing guidelines for a
cardiometabolic condition.
Improvements based on the pilot studies
From these pilots, we learned that the guideline can
be implemented in general practice. However, some
minor adjustment had to be made. Inviting people to
participate by sending a personal letter is much more
effective than simply putting up a poster and having
leaﬂets available at the practice. Furthermore, because
age is such an important risk factor, it is justiﬁable to
invite all patients over the age of 60 years (men) and
65 years (women) for a consultation without completing
the questionnaire. The response rate to the invitation
can be increased by also having a written questionnaire
available. This may also address the privacy concerns
people may have with an online questionnaire. Finally,
more efforts should be invested to convince people with
a high-risk score (above the threshold to go for follow-
up with their GP) to actually seek advice from their GP.
Further implementation
In 2011, further implementation of the PreventieCon-
sult CMR in general practice will take place. This
should consist of supporting health professionals in
providing the services stated in the guideline as well
as making the general public aware of the possibility
to take part in an integrated evidence-based health
check in general practice.
Professionals
In March 2011, the guideline has been published.
8 The
Dutch GPs already have 90 guidelines covering 70%
of the workload. Since the PreventieConsult CMR
has the format of such a guideline, it makes use of all
related quality aspects, such as supporting implemen-
tation materials, and uptake in the yearly updated
guideline book.
In addition to this, other professional organizations
will be involved in the wider implementation of the
recommendations of the guideline. As a ﬁrst step, the
Dutch occupational physicians are planning a pilot in
occupational health. On top of that, other professional
organizations or groups like community nurses, phar-
macists, physiotherapists and dieticians have shown an
interest in taking part in the wider implementation.
Also, commercial providers of health checks have of-
fered to replace their module on cardiometabolic dis-
eases by the PreventieConsult CMR.
We advocate the principles behind the Preventie-
Consult. This means that only persons not in care yet
for the index diseases should be invited. In addition,
good arrangements for referral (to the general prac-
tice) and lifestyle advice should be available and for-
malized. Finally, the PreventieConsult CMR is not a
one-time initiative. Therefore, the provider should be
willing to make longer term arrangements for follow-
up and repeated invitations.
When GPs chose for inviting persons, we advise to
invite the eligible population in small age cohorts. This
enables efﬁcient planning and facilitates an easier re-
invitation for the non-responders. However, GPs are
free to chose their approach and some GP practices
will prefer to start with the passive approach. Since
we do not have deﬁnite proof of cost-effectiveness of
either of the approaches, the policy for invitation will
be up to the practices themselves.
Public
The Dutch population is very interested in a reliable
health check (as a result of the collaborative initiative
from the six parties), especially offered by a health
care professional such as the GP.
3
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opment of the PreventieConsult CMR will play a major
role in making the public aware of the PreventieCon-
sult and to encourage the people to complete the risk
questionnaire by way of their means of communication.
Together with the launch of the guideline for professio-
nals, a user-friendly website for the general public has
been launched. In addition to the risk estimation, this
website provides tailored lifestyle advice especially for
those people who, because of their risk estimate, are
not recommended to seek advice from their GP
(www.testuwleefstijl.nl).
Challenges
The PreventieConsult CMR is a nationwide integrated
evidence-based preventive programme for cardiome-
tabolic disease. It has been designed on the cutting
edge between public health and primary care. Bridg-
ing these two worlds is not easy
2 but considered as
the only way to effectively deal with the increasing
burden of lifestyle-related chronic disease.
1
Adequate reimbursement of the participating profes-
sionals seems to be an essential factor for further imple-
mentation. Many of them do not yet consider this type
of active life style-oriented prevention a role for the
care providers,
16 while the workload implications of
such programmes are substantial.
17 For the acceptance
on the longer term, a parallel cost-effectiveness study is
planned, which also enables us to make adaptations on
aspects that are not sufﬁciently (cost-)effective.
In addition, proper collaboration between primary
care and public health is essential for the longer term
containment of the programme. It is important to
reach the lower socio-economic groups and the ethnic
minorities, who we know suffer more frequently from
CVD, DM2 or CKD. Some will argue that screening
on cardiometabolic diseases will only widen health
inequalities.
18 In general, this is true. However, be-
cause of the frequent contacts, high conﬁdence and
the low threshold primary care can play an important
role in minimizing this gap.
19,20 Primary care then acts
as a part of a selective prevention approach, which
requires a local community orientation.
21 Besides
professionals, the Municipal health services and the
municipalities themselves also play an important role
in creating an intersectoral community action for
health.
1,2,20
The success of the programme will not be deter-
mined by the identiﬁcation of subjects at high risk on-
ly. Some will argue that the focus needs to be on
detecting early stages of disease itself instead of focus-
sing on risk factors.
22 However, at present, there is still
insufﬁcient evidence for that.
23 Although some screen
positives will in the end need and proﬁt from medica-
tion, the main focus should be on risk factors and
lifestyle adaptation, which needs a concerted approach
between primary care and public health.
1,2,20
With the PreventieConsult CMR, we were able to es-
tablish a comprehensive national prevention initiative
focussed on one of the largest disease groups in the
western world. All parties involved (professionals, health
funds, patient organizations, municipal health services,
municipalities, health insurance companies, national
health bodies, commercial providers, etc.) will have to
take their own responsibility in the implementation of
this guideline and by doing so make a difference to
the health of many people. However, some important
issues still need to be addressed. The evidence for
cost-effectiveness of the whole approach (one of the
criteria of Wilson and Jungner) is still lacking. Speciﬁc
approaches to vulnerable groups (ethnic minorities and
lower socio-economic status) need to be developed,
aimed at improving participation as well as increasing
compliance to advice. There is a need for evidence-
based approaches for community-oriented collabora-
tion between primary care and public health.
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